Drawing for LUBRITEQ

USPTO serial 99465626

LUBRITEQ

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
SOBRAL, CHRISTINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LUBRITEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica S. Sachs

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.100 Bloomfield Hills ParkwaySuite 200Bloomfield Hills, MI 48304

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science and chemical preparations for use in photography; unprocessed plastics; biological preparations for use in industry and science; polymer resins in their raw state; polymeric substances with hydrophilic properties for use in manufacturing coatings for medical devices; chemical coatings in the nature of hydrophilic coatings for use in the manufacture of medical devices and pharmaceutical preparations; chemical compositions in the nature of hydrophilic coatings for use in the manufacture of polymer coatings for medical devicesACTIVE—
002Hydrophilic coatings for medical devices and veterinary devices; coatings for medical devices, for delivery of a wide range of pharmaceuticals, sold separately from the medical devices; Hydrophilic coatings for medical devices; hydrophilic coatings for medical devices; hydrophilic surface coatings for medical devices; hydrophilic polymer coatings for medical devicesACTIVE—
005Surgical implants comprising of living tissue with hydrophilic coatingACTIVE—
010Hydrophilic coating sold as an integral component of surgical, medical, dental and veterinary apparatus and instruments, namely, catheters, medical guidewires, hydrophilic guidewires to track catheters, medical endoscopes, stent delivery systems, synthetic stent grafts, artificial vascular grafts, and vascular sheaths; Surgical, medical, dental and veterinary apparatus and instruments, namely, surgical implants comprised of artificial materials with hydrophilic coating, drug-device products in the nature of syringes and infusion sets with hydrophilic coatings, catheters, medical guidewires, medical introducers and introducer sheaths, catheter tubes, synthetic stent grafts and stent delivery systems, endoscopic and minimally invasive surgical instruments, surgical instruments, implant drug delivery port systems comprised of drug delivery catheters, implantable drug delivery ports, implantable drug delivery pumps, vascular ports, drug delivery devices in the nature of implantable drug delivery pumps, wound care products in the nature of medical devices for closing wounds, medical diagnostic devices and microfluidic devices for medical purposes with hydrophilic coating, artificial heart parts, artificial heart valves, articles for medical use for the contact with blood in the nature of collecting tubes for blood, valves in the nature of valve assembly set which processes human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions, blood containers for medical purposes sold empty, blood collection bags for medical purposes, blood collection cans for medical purposes, blood collection needles, catheter and artificial parts in the nature of catheters and tubing for catheters for the cardiovascular system and the extracorporeal circulation except vascular filtration devices; surgical implants comprising of artificial materials, anti-thrombotic and anti-coagulative surgical implants comprising of artificial materials, surgical implants comprising of artificial materials coated with heparin, heparin derivatives or macromolecular agents, articles for medical use and for the contact with blood in the nature of apparatus for blood analysis, apparatus for taking blood, blood collection needles, and blood testing apparatus coated with heparin, heparin derivatives or macromolecular agents in the nature of tubes for blood, valves in the nature of valve assembly set which processes human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions, blood containers for medical purposes sold empty, blood collection bags for medical purposes, blood collection cans for medical purposes, blood collection needles, catheter and artificial parts in the nature of catheters and tubing for catheters for the cardiovascular system and the extracorporeal circulation, vascular filtration devices; artificial limbs, eyes and teeth; massage apparatus for medical use; medical devices, namely, artificial and natural surfaces in the nature of blood-contacting medical device surfaces, vascular and endovascular device surfaces, implantable medical device surfaces, drug-delivery system surfaces, surgical and endoscopic instrument surfaces, diagnostic and microfluidic device surfaces, wound-management device surfaces, and surgical implants comprised of artificial tissue with hydrophilic coating, drug-device products in the nature of implantable drug delivery pumps with hydrophilic coatings, catheters, medical guidewires, medical introducers and introducer sheaths, catheter tubes, synthetic stent grafts and stent delivery systems, endoscopic and minimally invasive surgical instruments, surgical instruments, implant drug delivery port systems comprised of drug delivery catheters, implantable drug delivery ports, implantable drug delivery pumps, vascular ports, drug delivery devices in the nature of implantable drug delivery pumps, wound care products in the nature of medical devices for closing wounds, medical diagnostic devices and microfluidic devices for medical purposes with hydrophilic coating, artificial heart parts, artificial heart valves, articles for medical use for the contact with blood in the nature of collecting tubes for blood, valves in the nature of valve assembly set which processes human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions, blood containers for medical purposes sold empty, blood collection bags for medical purposes, blood collection cans for medical purposes, blood collection needles, catheter and artificial parts in the nature of catheters and tubing for catheters for the cardiovascular system and the extracorporeal circulation except vascular filtration devicesACTIVE—
040Treatment of materials, namely, treatment of metals, polymers, elastomers, glass, ceramics, composites; commissioned application of coatings via a wet chemical process to medical devices surfaces; application of hydrophilic coatings via a wet chemical process to medical devicesACTIVE—
042Scientific and technological services, namely, scientific research, analysis, and testing in the field of hydrophilic coatings and research and design relating thereto; Industrial research in the field of hydrophilic coatings and design relating thereto; Industrial analysis of hydrophilic coatings, industrial research in the field of hydrophilic coatings and industrial design services; quality control for others; providing biochemical, pharmaceutical and medicine-technological research services; Product and scientific research and development in the field of coatings relating to medical devices; Commissioned product and scientific research, commissioned product development work and related consultancy in the field of coating surfaces for medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 8, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 8, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 8, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 8, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 7, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 29, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 2, 2026GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Sep 2, 2026GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Sep 2, 2026CNCFACTION CONTINUING A FINAL - COMPLETED—
Aug 31, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 16, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 16, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 16, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 15, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 15, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 12, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 28, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance